Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Peptic Ulcer 1Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer 1Gastritis 1Dyspepsia 1

Interventions

Oxaliplatin 300Fluorouracil 272Bevacizumab 237Gemcitabine 236Leucovorin 212Capecitabine 207pembrolizumab 201Nivolumab 158Irinotecan 158Cisplatin 150Specimen Handling 144Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 118Paclitaxel 109durvalumab 107Cetuximab 104Radiotherapy 99atezolizumab 94Drug Therapy 94Biopsy 93tislelizumab 81Albumin-Bound Paclitaxel 81Taxes 74Folfox protocol 68lenvatinib 67Carboplatin 66regorafenib 60Blood Specimen Collection 60sintilimab 54Ipilimumab 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Furazolidone × Gastrointestinal × 1 year × Clear all
NCT07139366 2025-12-02

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Xijing Hospital of Digestive Diseases

Phase 4 Recruiting
1,248 enrolled
Gastrointestinal

Dyspepsia, Gastritis, Peptic Ulcer, Stomach Neoplasms

NCT06168084 2025-07-03

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Xijing Hospital of Digestive Diseases

Phase 4 Completed
688 enrolled
Gastrointestinal

Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡